Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
Providence Portland Medical Center, Portland, Oregon NEXT Oncology, Austin, Texas China
The First Affiliated Hospital Nanchang Univeristy, Nanchang, Jiangxi Shandong Cancer Hospital, Jinan, Shangdong Shanghai East Hospital, Shanghai Shanghai General Hospital, Shanghai Shanghai GoBroad Cancer Hospital China Pharmaceutical University, Shanghai Last updated September 2025